• Home
  • NEW DAY MEDICINE
  • 10 (84) 2025
  • 138 -10 (84) 2025 - Aslanova M.Zh., Khamraeva G.B. - PROGNOSTIC VALUE OF LABORATORY PARAMETERS FOR ASSESSING THE RISK OF UTERINE LEIOMYOMA IN WOMEN

138 -10 (84) 2025 - Aslanova M.Zh., Khamraeva G.B. - PROGNOSTIC VALUE OF LABORATORY PARAMETERS FOR ASSESSING THE RISK OF UTERINE LEIOMYOMA IN WOMEN

PROGNOSTIC VALUE OF LABORATORY PARAMETERS FOR ASSESSING THE RISK OF UTERINE LEIOMYOMA IN WOMEN

Aslanova M.Zh. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Khamraeva G.B. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Uterine fibroids are benign, well-demarcated, encapsulated tumors originating from the smooth muscle cells of the cervix or body of the uterus. They are known to occur in one in four to five women, or approximately 25% of women over 35 years of age. Some data suggest that up to 70% of women of reproductive age may have uterine fibroids. According to pathological studies, uterine fibroids are detected in 80%. In reproductive age, the incidence of fibroids is 20-40%, and they are also associated with 5 to 10% of female infertility cases. Current research in this area requires cellular and subcellular studies following invasive examinations of this area.

Keywords: prognostic value of laboratory parameters, risk of developing uterine fibroids in women.

First page

787

Last page

793

For citation:Aslanova M.Zh., Khamraeva G.B. - PROGNOSTIC VALUE OF LABORATORY PARAMETERS FOR ASSESSING THE RISK OF UTERINE LEIOMYOMA IN WOMEN//New Day in Medicine 10(84)2025 787-793 https://newdayworldmedicine.com/en/new_day_medicine/10-84-2025

List of References

  1. A.I. Shapovalova, A.A. Tsypurdeeva, M.I. Kakhiani, E.N. Popov, V.O. Polyakova // Molekulyarnaya meditsina. 2019;17(9):60-63
  2. Cohen LA, et al. Serum ferritin is derived primarily from mac rophages through a nonclassical secretory pathway. 2010;116(9):1574-1584.
  3. Fennessy F.M., Tempany C.M. A review of magnetic resonance imaging-guided focused ultrasound surgery of uterine fibroids. Top. Magn. Reson. Imag., 2016.
  4. Francisco Veas Acute Phase Proteins — Regulation and Functions of Acute Phase Proteins. 2011.
  5. Lalueza A, et al. Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection. Clinical Microbiology and Infection. 2020;26(11):1557.e9-1557.e15.
  6. leiomyoma and metabolic syndrome in parous premenopausal women: A case control study / Y.J. MM, Shamugiya NM. The experience of uterine fibroids treatment with selective progesterone-receptor modulator. // Modern reproductive technologies. 2014;20(4):34-38.
  7. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM. Fer ritin and the response to oxidative stress. Biochemical Journal. 201;357(1):241-247.
  8. Ruscitti P, et al. Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations. Sci Rep. 2020;10(1):12232.
  9. S.Y. Lee, S.K. Park // Medicine. - 2016. - Vol. 95, N 4С. 28–32
  10. Soundravally R, Agieshkumar B, Daisy M, Sherin J, Cleetus CC. Ferritin levels predict severe dengue. Infection. 2015;43(1):13-19
  11. Tempany C.M., Stewart E.A., McDannold N. et al. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology. 2013;
  12. Uterine fibroids: diagnosis, treatment and rehabilitation: clinical Andreeva, N.V. Artymuk ., 2015. – 100 p.
  13. Van de Veerdonk FL, et al. IL-18 Serum Concentration Is Markedly Elevated in Acute EBV Infection and Can Serve as a Marker for Dis ease Severity. // The Journal of Infectious Diseases. 2012;206(2):197-201.
  14. Zhao G, Arosio P, Chasteen ND. Iron(II) and hydrogen peroxide detoxification by human H-chain ferritin. An EPR spin-trapping study. Biochemistry. 2006; 3429-3436.
  15. Адамян Л.В., Сонова М.М., Шамугия Н.М. Опыт применения селективных модуляторов рецепторов прогестерона в лечении миомы матки // Проблемы репродукции. —2014. — Т. 20. — № 4. — С. 34–38.
  16. Алибеков О. О. Частота встречаемости и патоморфологические особенности миомы матки у женщин в зависимости от возраста и количества беременностей // Экономика и социум. – 2022;8(99):125-129.
  17. Ахмедова Н.М.., Туланова Д.Ш. Особенности липидного обмена и гормонального статуса у женщин в менопаузе // Пробелемы биологии и медицины. - Самарканд, 2019;4-2:26-28.
  18. Бабаджанова Г. С., Султанмуратова Г. У. Влияние хлормадинон содержащих контрацептивов на углеводный и липидный обмены у женщин с метаболическим синдромом. – 2021.
  19. Бабаева Н. И. и др. Миома матки и её ассоциация с метаболическим синдромом у женщин репродуктивного возраста // Acta Biomedica Scientifica. 2022;7(5-1):27-34.
  20. В.Е. Радзинский, Г.Ф. Тотчиев - М.: Редакция журнала Status Praesens, 2014; 24 стр.

    file

    download